
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About
Moolec Science SA Ordinary Shares (MLEC)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: MLEC (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $3
1 Year Target Price $3
0 | Strong Buy |
1 | Buy |
0 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -27.53% | Avg. Invested days 23 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 28.40M USD | Price to earnings Ratio - | 1Y Target Price 3 |
Price to earnings Ratio - | 1Y Target Price 3 | ||
Volume (30-day avg) 1 | Beta -0.32 | 52 Weeks Range 5.30 - 11.00 | Updated Date 06/29/2025 |
52 Weeks Range 5.30 - 11.00 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -2.1 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -21.69% | Return on Equity (TTM) -174.68% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 48558480 | Price to Sales(TTM) 3.48 |
Enterprise Value 48558480 | Price to Sales(TTM) 3.48 | ||
Enterprise Value to Revenue 6.2 | Enterprise Value to EBITDA -1.01 | Shares Outstanding 4000370 | Shares Floating 897815 |
Shares Outstanding 4000370 | Shares Floating 897815 | ||
Percent Insiders 27.12 | Percent Institutions 0.13 |
Analyst Ratings
Rating 1 | Target Price 3 | Buy 1 | Strong Buy - |
Buy 1 | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Moolec Science SA Ordinary Shares
Company Overview
History and Background
Moolec Science SA is a food-tech company focused on producing animal proteins in plants using molecular farming. Founded in 2020, it aims to create sustainable and affordable alternatives to animal products.
Core Business Areas
- Molecular Farming: Developing and producing animal proteins within plants to create ingredients for the food industry.
- Hybrid Plant-Based Foods: Utilizing molecular farming to enhance the taste, texture, and nutritional profile of plant-based foods.
Leadership and Structure
The leadership team consists of Gastu00f3n Paladini (CEO), based out of Europe and a Board of Directors that guides the company's strategy.
Top Products and Market Share
Key Offerings
- SPC (Soy Protein Concentrate) with Bovine Myoglobin: Moolec's lead product, Piggy Sooy, aims to improve the taste and texture of plant-based meat alternatives by incorporating bovine myoglobin into soybeans. Market share is still emerging. Competitors include Impossible Foods, Beyond Meat.
- Gamma Linolenic Acid (GLA) from Safflower: GLA safflower oil can be used in supplements and food products. Market share is still emerging. Competitors are manufacturers of GLA supplements and oils.
Market Dynamics
Industry Overview
The plant-based and cultivated meat industries are experiencing significant growth, driven by increasing consumer demand for sustainable and ethical food options. However, taste and cost remain key challenges.
Positioning
Moolec aims to differentiate itself by using molecular farming to produce animal proteins in plants, potentially offering a cost-effective and scalable solution compared to traditional animal agriculture and cell-based meat production.
Total Addressable Market (TAM)
The TAM for plant-based meat alternatives and cultivated meat is estimated to reach billions of dollars in the coming years. Moolec is positioned to capture a share of this market by addressing the taste and cost challenges of existing plant-based products.
Upturn SWOT Analysis
Strengths
- Innovative technology (molecular farming)
- Potential for cost-effective production
- Sustainable approach
- Focus on improving taste and texture of plant-based foods
Weaknesses
- Early stage company
- Limited commercial production
- Regulatory hurdles for genetically modified crops
- Public perception of genetically modified foods
Opportunities
- Growing demand for plant-based and cultivated meat
- Partnerships with food companies
- Expansion into new markets
- Technological advancements in molecular farming
Threats
- Competition from established players in the plant-based and cultivated meat industries
- Changing consumer preferences
- Regulatory changes
- Scientific uncertainty and technological challenges
Competitors and Market Share
Key Competitors
- BYND
- IMPOSSIBLE FOODS (PRIVATE)
- TATTL (PRIVATE)
Competitive Landscape
Moolec is a small player compared to established plant-based meat companies and is very innovative compared to the larger competitors. It is focused on specific ingredient markets.
Growth Trajectory and Initiatives
Historical Growth: Limited historical data.
Future Projections: Future growth depends on the successful commercialization of Piggy Sooy and other products. Analyst estimates vary.
Recent Initiatives: Focus on scaling up production and securing regulatory approvals.
Summary
Moolec Science SA is an early-stage company with an innovative approach to producing animal proteins in plants. While it faces significant challenges, including regulatory hurdles and competition from established players, the growing demand for sustainable and affordable food options presents a significant opportunity. The company's success hinges on the successful commercialization of its products and the scalability of its molecular farming technology. Moolec needs to focus on securing regulatory approvals, scaling up production, and building strategic partnerships to gain market share. MOLE is highly volatile and high risk, but potentially very high reward.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company website
- Press releases
- Industry reports
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. The information provided is based on publicly available data and analyst estimates, which are subject to change. Investing in early-stage companies involves significant risks.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Moolec Science SA Ordinary Shares
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2023-01-03 | CEO - | ||
Sector Healthcare | Industry Biotechnology | Full time employees - | Website https://moolecscience.com |
Full time employees - | Website https://moolecscience.com |
Moolec Science SA operates as a science-based food ingredient company. The company is based in Grand Cayman, Cayman Islands.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.